Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Chemical Engineering (834)
- Materials Science and Engineering (550)
- Biomedical Engineering and Bioengineering (510)
- Industrial Engineering (205)
- Operations Research, Systems Engineering and Industrial Engineering (205)
-
- Civil and Environmental Engineering (201)
- Environmental Engineering (105)
- Engineering Education (97)
- Electrical and Computer Engineering (28)
- Biochemical and Biomolecular Engineering (5)
- Nanoscience and Nanotechnology (3)
- Semiconductor and Optical Materials (3)
- Energy Systems (1)
- Mechanical Engineering (1)
- Keyword
-
- Fluidization Technology (86)
- Biochar (38)
- Bioenergy (32)
- Thermal Barrier Coatings (32)
- Perfusion (31)
-
- E-technologies (30)
- Pyrolysis (29)
- Fluidized bed (22)
- CFB (20)
- CHO (20)
- CFD (19)
- Metabolic Engineering (19)
- Biomass (18)
- CHO cells (18)
- Phosphates (18)
- Hydrodynamics (17)
- Clean Energy (14)
- Earthquake (14)
- Functional Glasses (14)
- Landslide (14)
- Fluidized Bed (13)
- Materials Genome (13)
- Presentations (13)
- Product quality (13)
- LCA (11)
- Modeling (11)
- Nanotechnology (11)
- Posters (11)
- Risk (11)
- Scale-up (11)
- Publication Year
- Publication
-
- Cell Culture Engineering XV (246)
- The 14th International Conference on Fluidization – From Fundamentals to Products (132)
- The 12th International Conference on Fluidization - New Horizons in Fluidization Engineering (131)
- Nanomechanical Testing in Materials Research and Development V (123)
- The 13th International Conference on Fluidization - New Paradigm in Fluidization Engineering (122)
-
- Composites at Lake Louise (CALL 2015) (112)
- 10th International Conference on Circulating Fluidized Beds and Fluidization Technology - CFB-10 (95)
- Integrated Continuous Biomanufacturing II (85)
- Fluidization XV (72)
- Electric Field Assisted Sintering and Related Phenomena Far From Equilibrium (70)
- Heat Exchanger Fouling and Cleaning VII (63)
- BIO-CHAR: Production, Characterization and Applications (62)
- 5th International Conference on Porous Media and Their Applications in Science, Engineering and Industry (59)
- Single-Use Technologies: Bridging Polymer Science to Biotechnology Applications (57)
- CO2 Summit II: Technologies and Opportunities (55)
- BioEnergy IV: Innovations in Biomass Conversion for Heat, Power, Fuels and Chemicals (51)
- Wastewater and Biosolids Treatment and Reuse: Bridging Modeling and Experimental Studies (50)
- Bioenergy - I: From Concept to Commercial Processes (49)
- Bioenergy - II: Fuels and Chemicals from Renewable Resources (49)
- Enhanced, Compact and Ultra-Compact Heat Exchangers: Science, Engineering and Technology (49)
- Heat Exchanger Fouling and Cleaning - Challenges and Opportunities (49)
- Vaccine Technology IV (48)
- Thermal Barrier Coatings IV (47)
- Geohazards (46)
- Heat Exchanger Fouling and Cleaning: Fundamentals and Applications (44)
- CO2 Summit: Technology and Opportunity (40)
- Bioenergy III: Present and New Perspectives on Biorefineries (38)
- Pyroliq 2019: Pyrolysis and Liquefaction of Biomass and Wastes (37)
- Teaching Entrepreneurship to Engineering Students (36)
- Vaccine Technology III (35)
- File Type
Articles 1861 - 1890 of 2957
Full-Text Articles in Engineering
Plant-Made Influenza Virus-Like Particles: For Pandemic And Beyond, Nathalie Charland
Plant-Made Influenza Virus-Like Particles: For Pandemic And Beyond, Nathalie Charland
Vaccine Technology IV
No abstract provided.
Mutiply Activated Vlp Influenza Vaccines, James Swartz, Yuan Lu, John Welsh, Wei Chan
Mutiply Activated Vlp Influenza Vaccines, James Swartz, Yuan Lu, John Welsh, Wei Chan
Vaccine Technology IV
No abstract provided.
Novel Glycoconjugate Vaccines Based On Rationally Designed Synthetic Carbohydrate Antigens, Stwewart Campbell
Novel Glycoconjugate Vaccines Based On Rationally Designed Synthetic Carbohydrate Antigens, Stwewart Campbell
Vaccine Technology IV
No abstract provided.
Purification Of Cell-Based Influenza H5n1 Viruses By Liquid Chromatography Technologies, Alan Yung-Chih Hu
Purification Of Cell-Based Influenza H5n1 Viruses By Liquid Chromatography Technologies, Alan Yung-Chih Hu
Vaccine Technology IV
No abstract provided.
Flunisyn: Advanced Development Of A Synthetic Universal Influenza T-Cell Vaccine, Campbell Bunce
Flunisyn: Advanced Development Of A Synthetic Universal Influenza T-Cell Vaccine, Campbell Bunce
Vaccine Technology IV
No abstract provided.
Viral Sensitizer Technology Improves Yield Of Modified Vaccinia Ankara From Available Cell Substrates, Facrice Le Boeuf
Viral Sensitizer Technology Improves Yield Of Modified Vaccinia Ankara From Available Cell Substrates, Facrice Le Boeuf
Vaccine Technology IV
No abstract provided.
Monolithic Columns For Purification And In-Process Control Of Viruses And Virus-Like Particles, Lidija Urbas, Milos Barut
Monolithic Columns For Purification And In-Process Control Of Viruses And Virus-Like Particles, Lidija Urbas, Milos Barut
Vaccine Technology IV
No abstract provided.
Endotoxin-Free E. Coli Hosts For Vaccine Discovery And Production, David Bramhill
Endotoxin-Free E. Coli Hosts For Vaccine Discovery And Production, David Bramhill
Vaccine Technology IV
No abstract provided.
Bacterium-Like Particles As Delivery Vehicles For Multimeric Antigens, Kees Leenhouts
Bacterium-Like Particles As Delivery Vehicles For Multimeric Antigens, Kees Leenhouts
Vaccine Technology IV
No abstract provided.
Utilizing ‘Omics Tools To Investigate The Impact Of Process Changes On Product Quality In Cell Culture-Based Influenza Vaccine Production, E. Rapp, J. Rodig, J. Schwarzer, D. Hoeper, R. Hennig, Y. Genzel, U. Reichl
Utilizing ‘Omics Tools To Investigate The Impact Of Process Changes On Product Quality In Cell Culture-Based Influenza Vaccine Production, E. Rapp, J. Rodig, J. Schwarzer, D. Hoeper, R. Hennig, Y. Genzel, U. Reichl
Vaccine Technology IV
No abstract provided.
Suspension Vero Cells (Svero) For Poliovirus Production: Effect Of Culture Passage On Growth Kinetics And Productivity, Guillermina Forno
Suspension Vero Cells (Svero) For Poliovirus Production: Effect Of Culture Passage On Growth Kinetics And Productivity, Guillermina Forno
Vaccine Technology IV
No abstract provided.
Systematically Characterizing Adventitious Agent Tests For Biologics, Rebecca Sheets
Systematically Characterizing Adventitious Agent Tests For Biologics, Rebecca Sheets
Vaccine Technology IV
No abstract provided.
Automation And Multiplexing Of Immunoassays: Improving Precision And Throughput, Ilia Tikhonov
Automation And Multiplexing Of Immunoassays: Improving Precision And Throughput, Ilia Tikhonov
Vaccine Technology IV
No abstract provided.
Microbial Fermentation: New Tools To Speed-Up Vaccine Antigen Development And Increase Process Knowledge, Catherine Jourdat
Microbial Fermentation: New Tools To Speed-Up Vaccine Antigen Development And Increase Process Knowledge, Catherine Jourdat
Vaccine Technology IV
No abstract provided.
Building Pandemic Preparedness Through A Sustainable Enterprise For Influenza Vaccines, Robert Huebner
Building Pandemic Preparedness Through A Sustainable Enterprise For Influenza Vaccines, Robert Huebner
Vaccine Technology IV
No abstract provided.
High Cell Density Cultivations For Influenza Virus Production Using Suspension Cells, Y. Genzel, T. Vogel, J. Buck, I. Behrendt, G. Schiedner, I. Jordan, U. Reichl
High Cell Density Cultivations For Influenza Virus Production Using Suspension Cells, Y. Genzel, T. Vogel, J. Buck, I. Behrendt, G. Schiedner, I. Jordan, U. Reichl
Vaccine Technology IV
No abstract provided.
Rmce-Based Sf9 Cell Factory For Production Of Multi-Meric Vlps, Ana Teixera
Rmce-Based Sf9 Cell Factory For Production Of Multi-Meric Vlps, Ana Teixera
Vaccine Technology IV
No abstract provided.
Bacterial Expression Of A Vlp Sub-Unit For Rapid And Cheap Influenza Vaccination, Anton Middelberg
Bacterial Expression Of A Vlp Sub-Unit For Rapid And Cheap Influenza Vaccination, Anton Middelberg
Vaccine Technology IV
No abstract provided.
Developing A Suite Of Analytics To Support Process Development For The Manufacture Of Polysaccharides, Aaron Noyes, Ranga Godavarti, Nigel Titchener-Hooker, Jonathan Coffman, Tarit Mukhopadhyay
Developing A Suite Of Analytics To Support Process Development For The Manufacture Of Polysaccharides, Aaron Noyes, Ranga Godavarti, Nigel Titchener-Hooker, Jonathan Coffman, Tarit Mukhopadhyay
Vaccine Technology IV
No abstract provided.
Cervical Cancer Immunotherapy: Induction Of Hpv Specific Ctls In Human Volunteers After Vgx-3100 Immunization, Niranjan Sardesai
Cervical Cancer Immunotherapy: Induction Of Hpv Specific Ctls In Human Volunteers After Vgx-3100 Immunization, Niranjan Sardesai
Vaccine Technology IV
No abstract provided.
A Protein-Free Process And Product Protection System, Stephen Ward
A Protein-Free Process And Product Protection System, Stephen Ward
Vaccine Technology IV
No abstract provided.
Functional Genomics As A Tool To Define A Molecular Signature Of Effective Vaccination Against Foot And Mouth Disease Virus, Jose Chabalgoity
Functional Genomics As A Tool To Define A Molecular Signature Of Effective Vaccination Against Foot And Mouth Disease Virus, Jose Chabalgoity
Vaccine Technology IV
No abstract provided.
Oncolytic Viruses As Cancer Therapies, Stephen Rusell
Oncolytic Viruses As Cancer Therapies, Stephen Rusell
Vaccine Technology IV
No abstract provided.
Chimpanzee Ad Vector Technology Platform For Prophylactic And Therapeutic Genetic Vaccine Applications, Stefano Colloca
Chimpanzee Ad Vector Technology Platform For Prophylactic And Therapeutic Genetic Vaccine Applications, Stefano Colloca
Vaccine Technology IV
No abstract provided.
Challenges In Optimizing Formulations For Multi- Antigen Vaccines, Lakshmi Khandke
Challenges In Optimizing Formulations For Multi- Antigen Vaccines, Lakshmi Khandke
Vaccine Technology IV
No abstract provided.
A New Successful Vaccine Against Babesiosis: Any Use For Malaria?, Thep Schetters
A New Successful Vaccine Against Babesiosis: Any Use For Malaria?, Thep Schetters
Vaccine Technology IV
No abstract provided.
The Cmc Challenges In Developing An Oncolytic Immunotherapy, Colin Love
The Cmc Challenges In Developing An Oncolytic Immunotherapy, Colin Love
Vaccine Technology IV
No abstract provided.
High Throughput Formulation Design For A Stable Lyophilized Virus-Like Particle Vaccine Against Group A Streptococcu, Yap Chuan
Vaccine Technology IV
No abstract provided.
Process Development For A Peptide Conjugated Qbetavirus Like Particle (Vlp) Vaccine, Jennifer Thorn
Process Development For A Peptide Conjugated Qbetavirus Like Particle (Vlp) Vaccine, Jennifer Thorn
Vaccine Technology IV
No abstract provided.
Formulation And Stability Of A Chikungunya Virus-Like Particle (Chikv Vlp) Based Vaccine, Rhicard Schwartz
Formulation And Stability Of A Chikungunya Virus-Like Particle (Chikv Vlp) Based Vaccine, Rhicard Schwartz
Vaccine Technology IV
No abstract provided.